Moderate Pain — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for moderate pain. 15 active patents protecting 1 drugs from 1+ originators. First major cliff: 2032. Daily refresh.

1
Approved drugs
15
Active US patents
71/100
Avg vulnerability
—
Annual revenue covered

Originators in Moderate Pain

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Trevena 15 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating moderate pain. Each bar = one year. Y-axis scaled to peak year (15 patents).

15
32

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Olinvyk
OLICERIDINE
 Trevena 15 71 — 2032-03-23

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11931350 Olinvyk method of use 81 2032-03-23
11931350 Olinvyk method of use 81 2032-03-23
11931350 Olinvyk method of use 81 2032-03-23
8835488 Olinvyk method of use 68 2032-03-23
9642842 Olinvyk method of use 68 2032-03-23
11077098 Olinvyk method of use 68 2032-03-23
9309234 Olinvyk method of use 68 2032-03-23
9642842 Olinvyk method of use 68 2032-03-23
11077098 Olinvyk method of use 68 2032-03-23
9642842 Olinvyk method of use 68 2032-03-23

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9309234 Olinvyk method of use 68 2032-03-23
9309234 Olinvyk method of use 68 2032-03-23
9642842 Olinvyk method of use 68 2032-03-23
8835488 Olinvyk method of use 68 2032-03-23
9642842 Olinvyk method of use 68 2032-03-23
11077098 Olinvyk method of use 68 2032-03-23
8835488 Olinvyk method of use 68 2032-03-23
8835488 Olinvyk method of use 68 2032-03-23
11077098 Olinvyk method of use 68 2032-03-23
9642842 Olinvyk method of use 68 2032-03-23

Related